Australia's Largest Biotech Week Seeks Sessions, Speakers

Inspired by its theme 'United through Innovation', AusBiotech is welcoming submission for topics and speakers to inform Australia's largest life science conference, AusBiotech 2024, held in Melbourne from October 30-1 November.

As the flagship event of Australia's biggest week in biotech, AusBiotech 2024 unites more than 1,300 delegates each year and is the core event of Australia's 'biggest week in biotech'. Its programme committee is looking for high-calibre session submissions that explore current trends, critical and emerging topics, breakthroughs, and stories that are thought-provoking and encourage discussion.

The AusBiotech conference programme is developed by industry, for industry, and individuals are invited to submit your topic and speaker ideas for:

  • Keynote sessions (30 minutes in length, including Q&A)
  • Panel sessions (up to 90 minutes in length, with one chair and up to four speakers)
  • Individual panellists

Speaking at AusBiotech 2024 positions you as an international expert who tackles the most pressing issues in our industry, builds critical dialogue, sparks creative conversations, and profiles new technology.

For over 38 years, the AusBiotech conference has served as the leading international meeting place for the Australian life science community. It's time to bring Australian life sciences to the world stage - exploring what's possible across biotechnology, medical devices and agribiotech to heal and feed the world.

Biotechnology continues to unlock vast potential for improving human life. Join AusBiotech 2024, supported by the Victorian State Government, in Melbourne for in-person networking, cutting-edge programming and to advance our industry.

Click here

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.